Biotech Values

[vinmantoo]

{{How did such a disparity come about? (I know the history with respect to SLXP and Ono Pharmaceutical.)}}

Dew, I previously wrote 50%-%-60% of global (ex-US) sales. I checked it and the PGNX press release says 60% of revenues SLXP receives from ex-US sublicensees of Relistor, which is not the same as 60% of world wide revenues since obviously the sublicensee would get a nice cut. The payment percentages can be found in the link. Sorry for my error and for any confusion it might have caused.

http://globenewswire.com/news-release/2014/10/06/671018/10101390/en/Progenics-Receives-40-Million-Milestone-Following-FDA-Approval-of-RELISTOR-for-OIC-Patients-With-Chronic-Non-Cancer-Pain.html